ArticleClinical journal of gastroenterology2026
A case of multiple type I endocrine neoplasia with gastrin-producing and glucagon-producing tumors successfully resected 18 years after insulinoma surgery.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic neuroendocrine tumors (NETs) are common manifestations of multiple endocrine neoplasia type 1 (MEN1), whereas functional tumors such as gastrin-producing tumors are less frequent. Although gastrinomas associated with MEN1 have a high level of biological malignancy, they are considered fully treatable with surgical resection based on accurate localization. We report the case of a 27-year-old woman with MEN1 who had a gastrin-producing tumor and a glucagon-producing tumor removed 18 years after surgery for insulinoma. She had an increased gastrin concentration, and abdominal ultrasound and magnetic resonance imaging revealed an 18-mm tumor in the pancreatic tail. A selective arterial calcium injection test was positive for the gastroduodenal artery, but negative for the splenic artery. Therefore, we judged that the feeding artery for the gastrin-producing tumor was the gastroduodenal artery. Distal pancreatectomy and pancreaticoduodenectomy were performed. The resected specimen revealed 15 micro-gastrin-producing tumors measuring ≤ 5 mm, and six lymph node metastases in the duodenum and pancreatic head. The pancreatic tail tumor was a glucagon-producing tumor. In this case, long-term postoperative follow-up and accurate local diagnosis, including selective arterial calcium injection testing for gastrin-producing tumors, resulted in successful curative resection. It is important to keep in mind that various hormone-secreting tumors may occur simultaneously or metachronously in patients with MEN1.
Indexed as
Identifiers
41945253What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.